Increased Hb A2 values in an HIV-1-infected patient receiving antiretroviral drugs: A pitfall for thalassemia antenatal diagnosis

Hemoglobin

Volumn 33, Issue 2, 2009, Pages 158-161

  Pornprasert, Sakorn ^a   Sukunthamala, Kanyakan ^b   Leechanachai, Pranee ^a   Sanguansermsri, Torpong ^c  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Chiang Mai Neurological Hospital   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Antenatal diagnosis; Antiretroviral dmgs; Hb a2; Human immunodeficiency virus 1 (hiv 1); Thalassemia

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; HEMOGLOBIN A2; HEMOGLOBIN E; LAMIVUDINE PLUS ZIDOVUDINE;

ADULT; ARTICLE; BETA THALASSEMIA; CASE REPORT; DIAGNOSTIC ERROR; ERYTHROCYTE; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETIC TRAIT; GESTATIONAL AGE; HEMOGLOBINOPATHY; HETEROZYGOTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; OSMOTIC FRAGILITY; PRENATAL DIAGNOSIS; BLOOD; BLOOD EXAMINATION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; PREGNANCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTI-RETROVIRAL AGENTS; BETA-THALASSEMIA; FEMALE; HEMATOLOGIC TESTS; HEMOGLOBIN A2; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 67449096515     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260902813486     Document Type: Article

References (12)

1. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin. 1987;ll(l):65-88.
2. Fucharoen S, Winichagoon P, Thonglairoam V, Siriboon W, Siritanaratkul N, Kanokpongsakdi S, et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: Experience from 100 pregnancies. Southeast Asian] 'Prop Med Public Health. 1991;22(l):16-29.
3. Issaragrisil S, Visudhisakchai S, Suvatte V, Tanphaichir VS, Chandanayingyong D, Chongkolwatana V, et al. Bone marrow transplantation for thalassemia in Thailand. Bone Marrow Transplant. 1993;12(Suppl. l):42-44.
4. Dhamcharee V, Romyanan O, Ninlagarn T. Genetic counseling for thalassemia in Thailand: Problems and solutions. Soutlieast Asian J Trap Med Public Health. 2001;32(2) :413-418.
5. Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ. 2004;82(5):364-372.
6. Pansatiankul B, Saisorn S. A community-based thalassemia prevention and control model in northern Thailand. J Med Assoc Thai. 2003;86(Suppl. 3):S576-S582.
7. 2 values in HIV positive women in the antenatal clinic./Clin Pathol. 2005;58(5):556-558.
8. 2 in human immunodeficiency virus-l-infected patients treated with zidovudine. Am J Heinatol. 1993;43(2):86-90.
9. Wilkinson MJ, Bain BJ, Phelan L, Benzie A. Increased haemoglobin A2 percentage in HIV infection: Disease or treatment? AIDS. 2007;21(9):1207-1208.
10. Moyle G, Sawyer W, Law M, Amin J, Hill A. Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies. Clin Titer. 2004;26(l):92-97.
11. 2 :Origin, evolution, and aftermath. Blood. 1991;78(9):2165-2177.
12. Spiga MG, Weidner DA, Trentesaux C, LeBoeuf RD, Sommadossi JP. Inhibition of β-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells. Antiviral lies. 1999;44(3):167-177.